| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/07/2007 | CN1926433A Method for detecting the activatable free form of PSA and the use thereof for diagnosing benign pathologies of the prostate and adenocarcinoma of the prostate |
| 03/07/2007 | CN1926237A Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility |
| 03/07/2007 | CN1926153A Composition for treating pathology associated with MSRV/HERV-W |
| 03/07/2007 | CN1926149A Identification of novel IgE epitopes |
| 03/07/2007 | CN1926147A Nogo受体拮抗剂 Nogo receptor antagonist |
| 03/07/2007 | CN1926146A Antibody purification |
| 03/07/2007 | CN1925898A Antibody purification technique |
| 03/07/2007 | CN1925871A Polymer-bound antibody concer therapeutic agent |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1303209C Synthetase-1b for human cholesterol ester and coded sequence |
| 03/07/2007 | CN1303105C Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application |
| 03/06/2007 | US7186898 Nucleic acid molecules from maize and their use for the production of modified starch |
| 03/06/2007 | US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis |
| 03/06/2007 | US7186818 DNA encoding soluble variants of human OX2 receptors |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 03/06/2007 | US7186808 Isolated monoclonal antibody encoded by clone accession number PTA-4889. |
| 03/06/2007 | US7186804 IL-2 fusion proteins with modulated selectivity |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186800 Fc domains of immunoglobulins; fas genes/proteins; drug screening |
| 03/06/2007 | US7186681 Methods of modulating cell migration using galectin-3 |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186410 Method for preparing human immunoglobulin concentrates for therapeutic use |
| 03/06/2007 | CA2320488C Strategically modified hepatitis b core proteins and their derivatives |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/01/2007 | WO2007024846A2 Anit-il-23 antibiodies |
| 03/01/2007 | WO2007024735A2 Method and antibodies for detecting nitrofuran |
| 03/01/2007 | WO2007024249A2 Engineering fc antibody regions to confer effector function |
| 03/01/2007 | WO2007023782A1 Neutralizing antibody directed against killer toxin-like protein, and use thereof |
| 03/01/2007 | WO2007023316A2 Assay for trypanosome infection |
| 03/01/2007 | WO2007023298A2 Antibodies |
| 03/01/2007 | WO2007022668A1 Important lymphocyte activation regulatory protein pkd2 and uses thereof |
| 03/01/2007 | WO2007022557A1 Mimotopes of epstein-barr virus (ebv) epitopes |
| 03/01/2007 | WO2006136392A3 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/01/2007 | WO2006119965A3 Growth factor mutants with altered biological attributes |
| 03/01/2007 | WO2006117241A3 Polypeptide, vaccine and use thereof |
| 03/01/2007 | WO2006084466A3 Surface-located streptococcus pneumoniae polypeptides |
| 03/01/2007 | WO2006081573A3 Homogeneous preparations of il-31 |
| 03/01/2007 | WO2006072048B1 Compositions and methods for identifying modulators of hausp |
| 03/01/2007 | WO2006069200A3 Group b streptococcus |
| 03/01/2007 | WO2006061723B1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 03/01/2007 | WO2006054289A3 Therapeutic implant |
| 03/01/2007 | WO2006053110A3 Ovr110 antibody compositions and methods of use |
| 03/01/2007 | WO2006021955A3 Use of bat monoclonal antibody for immunotherapy |
| 03/01/2007 | WO2006013087A8 Human monoclonal antibodies against human il-4 |
| 03/01/2007 | WO2005017107A3 Specific binding agents to hepatocyte growth factor |
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | WO2003080675A3 MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1) |
| 03/01/2007 | US20070050869 Regulatory sequences useful for production of plants with modified embryo and/or endosperm development |
| 03/01/2007 | US20070049737 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049734 Ultra-high yield intravenous immune globulin preparation |
| 03/01/2007 | US20070049733 Ultra-high yield intravenous immune globulin preparation |
| 03/01/2007 | US20070049732 Ultra-high yield intravenous immune globulin preparation |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048861 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048826 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048820 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/01/2007 | US20070048811 Tumor suppressor designated TS10q23.3 |
| 03/01/2007 | US20070048810 ATP-binding cassette protein responsible for cytotoxin resistance |
| 03/01/2007 | US20070048809 Using monoclonal antibody NUH2 as diagnositic tool in identifying cell proliferative disorders of urogenital system in individual negative for prostate specific antigen |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048794 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/01/2007 | US20070048785 Anti-IL-13 antibodies and complexes |
| 03/01/2007 | US20070048784 Novel human hydrolase family members and uses thereof |
| 03/01/2007 | US20070048774 Continuous in-vitro evolution |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048332 Stabilized liquid anti-RSV antibody formulations |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048324 Antibody which binds fetal thymocytes, inhibitits cell proliferation and does not bind adult thymocytes; for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/01/2007 | US20070048322 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048315 monoclonal antibody, or antigen binding fragment thereof that binds to human IL-23p19 at an epitope comprising residues 133-140 of SEQ ID NO: 29; treatment of inflammatory, autoimmune, and proliferative disorders |
| 03/01/2007 | US20070048314 Process for preparing purified drug conjugates |
| 03/01/2007 | US20070048313 Hybridoma cell lines and monoclonal antibodies recognizing Prox1 |
| 03/01/2007 | US20070048312 Mixture comprising A beta -derived diffusible ligand (ADDL) specific immunoglobulin which binds soluble amyloid beta protein for use in diagnosis, prevention and treatment of nervous sytem disorders |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048304 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
| 03/01/2007 | US20070048303 Nucleic acid encoding cytokine receptor zcytor17 |
| 03/01/2007 | US20070048302 Interleukin-2 (IL-2); treating metastatic cancer, autoimmune disorders, and viral infections such as HIV by administering a peptide that peptide binds to the IL-2 beta chain |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048300 Antibodies having altered effector function and methods for making the same |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048264 Methods of treating cancer using il-21 and monoclonal antibody therapy |